CTI BioPharma

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CTI BioPharma and other ETFs, options, and stocks.

About CTIC

CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. 

CEO
Adam R. Craig
CEOAdam R. Craig
Employees
121
Employees121
Headquarters
Seattle, Washington
HeadquartersSeattle, Washington
Founded
1991
Founded1991
Employees
121
Employees121

CTIC Key Statistics

Market cap
676.02M
Market cap676.02M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
4.57M
Average volume4.57M
High today
$5.94
High today$5.94
Low today
$5.45
Low today$5.45
Open price
$5.62
Open price$5.62
Volume
3.02M
Volume3.02M
52 Week high
$7.80
52 Week high$7.80
52 Week low
$1.43
52 Week low$1.43

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

CTIC Earnings

-$0.41
-$0.27
-$0.14
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 11, After Hours
ActualExpected Nov 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.